Selig Named President of NCCR Board

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

YOU MAY BE INTERESTED IN

As the debate around Galleri, the multi-cancer detection test developed by GRAIL Inc., rages on, fueled most recently by the full-steam-ahead support it has received from regulatory and legislative bodies, NCI Director Anthony Letai has turned his attention to the available data.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login